Article thumbnail

The Induction of MicroRNA Targeting IRS-1 Is Involved in the Development of Insulin Resistance under Conditions of Mitochondrial Dysfunction in Hepatocytes

By Hyun Su Ryu, Seung-Yoon Park, Duan Ma, Jin Zhang and Wan Lee
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3064581
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1997). Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM.
  2. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
  3. (2003). Defective signaling through Akt-2 and -3 but not Akt-1 in insulin-resistant human skeletal muscle: potential role in insulin resistance.
  4. (2001). Depletion of mitochondrial DNA alters glucose metabolism in SK-Hep1 cells.
  5. (1998). Different subcellular distribution and regulation of expression of insulin receptor substrate (IRS)-3 from those of IRS-1 and IRS-2.
  6. (1997). Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse.
  7. (2002). Downregulated IRS-1 and PPARgamma in obese women with gestational diabetes: relationship to FFA during pregnancy.
  8. (2002). Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes.
  9. (1998). Effects of depletion of mitochondrial DNA in metabolism secretion coupling in INS-1 cells.
  10. (2006). Etiology of insulin resistance.
  11. (1989). Fluorescent labeling of mitochondria.
  12. (2009). Foxo1 integrates insulin signaling with mitochondrial function in the liver.
  13. (2004). Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes.
  14. (2009). Improved insulin sensitivity after weight loss and exercise training is mediated by a reduction in plasma fatty acid mobilization, not enhanced oxidative capacity.
  15. (1997). Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with noninsulin-dependent diabetes mellitus.
  16. (2001). Insulin resistance with low cellular IRS-1 expression is also associated with low GLUT4 expression and impaired insulin-stimulated glucose transport.
  17. (2002). Insulin signaling pathways in time and space.
  18. (2010). Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes.
  19. (2006). Mechanisms linking obesity to insulin resistance and type 2 diabetes.
  20. (2004). Medicine. Metabolic defects tied to mitochondrial gene.
  21. (2007). Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells.
  22. (2008). MicroRNA-126 regulates HOXA9 by binding to the homeobox.
  23. (2009). MicroRNAs: target recognition and regulatory functions. Cell 136: 215–233. Implication of MicroRNAs in
  24. (2001). Mitochondria-to-nucleus stress signaling induces phenotypic changes, tumor progression and cell invasion.
  25. (2008). Mitochondrial capacity in skeletal muscle is not stimulated by weight loss despite increases in insulin action and decreases in intramyocellular lipid content.
  26. (2004). Mitochondrial diabetes: molecular mechanisms and clinical presentation.
  27. (2005). Mitochondrial dysfunction and type 2 diabetes.
  28. (2006). Mitochondrial dysfunction induces aberrant insulin signalling and glucose utilisation in murine C2C12 myotube cells.
  29. (2004). Mitochondrial signaling: the retrograde response.
  30. (2008). Molecular medicine of microRNAs: structure, function and implications for diabetes.
  31. (2007). Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes.
  32. (1992). Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance.
  33. (1999). Retrograde Ca2+ signaling in C2C12 skeletal myocytes in response to mitochondrial genetic and metabolic stress: a novel mode of inter-organelle crosstalk.
  34. (2008). Role of mitochondrial dysfunction in insulin resistance.
  35. (2003). Sequence requirements for micro RNA processing and function in human cells.
  36. (2009). Skeletal muscle "mitochondrial deficiency" does not mediate insulin resistance.
  37. (1995). Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women.
  38. (2008). Skeletal muscle lipid oxidation and obesity: influence of weight loss and exercise.
  39. (2001). Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance.
  40. (2008). The cell growth suppressor, mir-126, targets IRS-1.
  41. (2008). The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers.